not tagged
abbott
[' teer ', 'triluminate']
in the open label triluminate trial, tricuspid teer was safe for patients with severe tricuspid regurgitation, reduced the severity of tricuspid regurgitation, and was associated with an improvement in quality of life at 1 year. #acc23 
Interventional Cardiologist | Professor of Cardiology at University of Catania, Italy | Editor-in-Chief of @EuroInterventio